- Home
- MIRA vs SRTS Comparison
MIRA vs SRTS Comparison
Compare MIRA & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MIRA | SRTS |
|---|---|---|
| Founded | 2020 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.1M | 67.5M |
| IPO Year | 2023 | 2016 |
Fundamental Metrics
Financial Performance| Metric | MIRA | SRTS |
|---|---|---|
| Price | $1.47 | $4.88 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | ★ 135.4K | 102.9K |
| Earning Date | 11-13-2025 | 02-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $35,609,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $29.12 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.73 | $3.03 |
| 52 Week High | $2.45 | $9.08 |
Technical Indicators
Market Signals| Indicator | MIRA | SRTS |
|---|---|---|
| Relative Strength Index (RSI) | 49.40 | 62.53 |
| Support Level | $1.38 | $4.87 |
| Resistance Level | $1.50 | $5.28 |
| Average True Range (ATR) | 0.05 | 0.38 |
| MACD | -0.01 | 0.05 |
| Stochastic Oscillator | 56.63 | 68.24 |
Price Performance
Historical ComparisonAbout MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.